Exxsun Corp (MNZO)
Manzo Pharmaceuticals, Inc. is a specialized drug company that focuses on the discovery, creation, and evaluation of both proprietary and generic medical treatments and therapies. The company is actively developing Lacto-Freedom, a patented probiotic designed to help individuals with lactose intolerance digest dairy-containing foods more easily. Additionally, it is crafting a natural solution for infant colic. Headquartered in Milford, Pennsylvania, the organization was formerly known as Fortune Oil & Gas, Inc. before adopting its current name, Manzo Pharmaceuticals, Inc., in September 2014.
Sector: Crude Petroleum & Natural Gas
Industry: Medical - Pharmaceuticals
Manzo Pharmaceuticals, Inc.
OTC:MNZOFinancial Services · Shell Companies
$0.0001
Mkt Cap$500K
Float397.78M
O/S5B
Inst Own-
Dilution
Delisting Issues Timeline
Financials Summary
Revenue$0
Net Income-$51K
Total Assets$192K
Free Cash Flow-$103K
Debt & Equity
Equity 106%
Preferred 0%
Total Debt-$11K
Total Equity$181K
Preferred Stock$444
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in MNZO's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$192K
Liabilities-$11K
Accounts Receivable$0
Accounts Payable$0
Inventory$0
PP&E (Net)$0
Goodwill$110K
Intangible Assets$70K
Income Statement
| Period | FY 2025 | FY 2015 | FY 2014 | FY 2004 | FY 2003 |
|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2015-12-31 | 2014-12-31 | 2004-12-31 | 2003-12-31 |
| Revenue | $0 | $2K | $548 | $3.07M | $3M |
| YoY Growth | - | 267.5% | -100.0% | 2.2% | - |
| Cost of Revenue | $0 | $1K | $0 | $3.05M | $2.25M |
| Gross Profit | $0 | $793 | $548 | $21K | $756K |
| Gross Margin | - | 39.4% | 100.0% | 0.7% | 25.2% |
| Research and Development | $15K | $0 | $0 | $0 | $0 |
| Selling, General, and Administrative | $38K | $0 | $246K | $2.87M | $3.05M |
| Other | $0 | $0 | $0 | $344K | $951K |
| Total Operating Expenses | $52K | $0 | $246K | $3.22M | $4M |
| Operating Income (EBIT) | -$52K | $793 | -$246K | -$3.2M | -$3.25M |
| Operating Margin | - | 39.4% | -44856.4% | -104.2% | -108.1% |
| Interest Expense | $0 | $36K | $540K | $914K | $803K |
| Interest Income | $1K | $0 | $0 | $0 | $0 |
| Other Income (Expense) | $1K | -$37K | -$743K | $3.2M | $3.25M |
| Income Before Tax (EBT) | -$51K | -$36K | -$989K | $0 | $0 |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$51K | -$36K | -$989K | -$4.15M | -$3.95M |
| Net Income Margin | - | -1799.6% | -180493.8% | -135.2% | -131.6% |
| Supplementary Data | |||||
| EPS | 0.00 | -0.00 | -0.00 | -1.20 | -1.20 |
| Diluted EPS | 0.00 | -0.00 | -0.00 | -1.20 | -1.20 |
| Weighted Average OS | 5.00B | 1.16B | 340.30M | 3.46M | 3.22M |
| EBITDA | -$52K | $793 | -$449K | -$2.85M | -$2.3M |
| EBITDA Margin | - | 39.4% | -81886.5% | -93.0% | -76.5% |
Balance Sheet
| Period | FY 2015 | FY 2014 | FY 2004 | FY 2003 |
|---|---|---|---|---|
| Currency | USD | USD | USD | USD |
| Period Ending | 2015-12-31 | 2014-12-31 | 2004-12-31 | 2003-12-31 |
| Assets | ||||
| Current Assets | ||||
| Cash and Cash Equivalents | $12K | $11K | $10K | $12K |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $12K | $11K | $10K | $12K |
| Accounts Receivable | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $1.44M |
| Other Current Assets | $0 | $0 | $138K | $141K |
| Total Current Assets | $12K | $11K | $148K | $1.6M |
| Long-Term Assets | ||||
| Property, Plant & Equipment Net | $0 | $0 | $1.14M | $1.29M |
| Goodwill | $110K | $0 | $0 | $0 |
| Intangible Assets | $70K | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $0 | $0 | $0 | $2.11M |
| Total Long-Term Assets | $180K | $0 | $1.14M | $3.39M |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $192K | $11K | $1.29M | $4.99M |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts Payable | $0 | $17K | $405K | $433K |
| Short-Term Debt | -$11K | $89K | $6.52M | $7.31M |
| Current Income Tax Payable | $0 | $0 | $1.49M | $2.15M |
| Current Unearned Revenue | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $0 | $73K | $1.78M | $1.07M |
| Total Current Liabilities | -$11K | $179K | $23.79M | $23.46M |
| Long-Term Liabilities | ||||
| Long-Term Debt | $0 | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $0 | $0 | $0 | $0 |
| Total Long-Term Liabilities | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Total Liabilities | -$11K | $179K | $23.79M | $23.46M |
| Stockholders' Equity | ||||
| Preferred Stock | $444 | $4K | $0 | $0 |
| Common Stock | $1.16M | $465K | $35K | $2 |
| Retained Earnings | -$12.4M | -$3.8M | -$31.37M | -$27.22M |
| Comprehensive Income & Other | $0 | $0 | -$24K | -$15K |
| Other Stockholders' Equity | $11.42M | $3.17M | $8.83M | $8.76M |
| Total Equity | $181K | -$168K | -$22.5M | -$18.46M |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $170K | $11K | $1.29M | $4.99M |
| Supplementary Data | ||||
| Total Debt | -$11K | $89K | $6.52M | $7.31M |
| Net Debt | -$23K | $79K | $6.51M | $7.3M |
Cash Flow Statement
| Period | FY 2025 | FY 2004 | FY 2003 |
|---|---|---|---|
| Currency | USD | USD | USD |
| Period Ending | 2025-12-31 | 2004-12-31 | 2003-12-31 |
| Operating Activities | |||
| Net Income | -$51K | -$4.15M | -$3.95M |
| Depreciation & Amortization | $0 | $0 | $0 |
| Deferred Income Tax | $0 | $0 | $0 |
| Stock-Based Compensation | $0 | $0 | $0 |
| Changes in Working Capital: | |||
| Accounts Receivable | $0 | $0 | $0 |
| Inventory | $0 | $1.44M | -$564K |
| Accounts Payable | $0 | $0 | $0 |
| Other Working Capital | $0 | $1.65M | $1.35M |
| Total Working Capital Change | $0 | $3.09M | $789K |
| Other Non-Cash Items | $0 | -$49K | $1.58M |
| Net Cash from Operating | -$51K | -$1.11M | -$1.58M |
| Investing Activities | |||
| Capital Expenditures | -$52K | -$2K | -$3K |
| Acquisitions | $0 | $0 | $0 |
| Purchases of Investments | $0 | $0 | $0 |
| Sales of Investments | $0 | $0 | $0 |
| Other Investing Activities | $0 | $0 | $0 |
| Net Cash from Investing | -$52K | -$2K | -$3K |
| Financing Activities | |||
| Debt Repaid | - | - | - |
| Common Stock Issuance | $216K | $0 | $0 |
| Common Stock Repurchases | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 |
| Other Financing Activities | $0 | $0 | $0 |
| Net Cash from Financing | $216K | $1.12M | $840K |
| Forex Effect | -$12K | -$9K | -$11K |
| Net Change in Cash | $101K | -$2K | -$757K |
| Supplementary Data | |||
| Operating Cash Flow | -$51K | -$1.11M | -$1.58M |
| Capital Expenditure | -$52K | -$2K | -$3K |
| Free Cash Flow | -$103K | -$1.11M | -$1.59M |
| Cash at Beginning | $12K | $12K | $769K |
| Cash at End | $113K | $10K | $12K |